Integra LifeSciences Corporation Statistics
Share Statistics
Integra LifeSciences Corporation has 77.16M shares outstanding. The number of shares has increased by -0.76% in one year.
| Shares Outstanding | 77.16M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.55% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 66.12M |
| Failed to Deliver (FTD) Shares | 592 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 5.18M, so 6.71% of the outstanding shares have been sold short.
| Short Interest | 5.18M |
| Short % of Shares Out | 6.71% |
| Short % of Float | 7.82% |
| Short Ratio (days to cover) | 7.11 |
Valuation Ratios
The PE ratio is 50.25 and the forward PE ratio is 9.85. Integra LifeSciences Corporation's PEG ratio is 0.84.
| PE Ratio | 50.25 |
| Forward PE | 9.85 |
| PS Ratio | 2.21 |
| Forward PS | 1.1 |
| PB Ratio | 2.14 |
| P/FCF Ratio | 46.58 |
| PEG Ratio | 0.84 |
Enterprise Valuation
Integra LifeSciences Corporation has an Enterprise Value (EV) of 4.89B.
| EV / Earnings | 72.23 |
| EV / Sales | 3.17 |
| EV / EBITDA | 17.86 |
| EV / EBIT | 43.87 |
| EV / FCF | 66.95 |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.94.
| Current Ratio | 3.45 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.94 |
| Total Debt / Capitalization | 48.57 |
| Cash Flow / Debt | 0.09 |
| Interest Coverage | 2.17 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on capital (ROIC) is 2.85%.
| Return on Equity (ROE) | 0.04% |
| Return on Assets (ROA) | 0.02% |
| Return on Capital (ROIC) | 2.85% |
| Revenue Per Employee | 390.67K |
| Profits Per Employee | 17.17K |
| Employee Count | 3.95K |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.68 |
Taxes
| Income Tax | 13.33M |
| Effective Tax Rate | 0.16 |
Stock Price Statistics
The stock price has increased by -43.75% in the last 52 weeks. The beta is 1.08, so Integra LifeSciences Corporation's price volatility has been higher than the market average.
| Beta | 1.08 |
| 52-Week Price Change | -43.75% |
| 50-Day Moving Average | 21.83 |
| 200-Day Moving Average | 26.09 |
| Relative Strength Index (RSI) | 57.73 |
| Average Volume (20 Days) | 892.29K |
Income Statement
In the last 12 months, Integra LifeSciences Corporation had revenue of $1.54B and earned $67.74M in profits. Earnings per share was $0.87.
| Revenue | 1.54B |
| Gross Profit | 888.39M |
| Operating Income | 111.53M |
| Net Income | 67.74M |
| EBITDA | 274.01M |
| EBIT | 111.53M |
| Earnings Per Share (EPS) | 0.87 |
Balance Sheet
The company has $276.40M in cash and $1.68B in debt, giving a net cash position of -$1.41B.
| Cash & Cash Equivalents | 276.40M |
| Total Debt | 1.68B |
| Net Cash | -1.41B |
| Retained Earnings | 946.86M |
| Total Assets | 4.07B |
| Working Capital | 186.96M |
Cash Flow
In the last 12 months, operating cash flow was $139.96M and capital expenditures -$66.86M, giving a free cash flow of $73.09M.
| Operating Cash Flow | 139.96M |
| Capital Expenditures | -66.86M |
| Free Cash Flow | 73.09M |
| FCF Per Share | 0.94 |
Margins
Gross margin is 57.63%, with operating and profit margins of 7.23% and 4.39%.
| Gross Margin | 57.63% |
| Operating Margin | 7.23% |
| Pretax Margin | 5.26% |
| Profit Margin | 4.39% |
| EBITDA Margin | 17.77% |
| EBIT Margin | 7.23% |
| FCF Margin | 4.74% |
Dividends & Yields
IART does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3.62% |
| FCF Yield | 3.94% |
Analyst Forecast
The average price target for IART is $22, which is -8.6% lower than the current price. The consensus rating is "Sell".
| Price Target | $22 |
| Price Target Difference | -8.6% |
| Analyst Consensus | Sell |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Jan 4, 2017. It was a forward split with a ratio of 2:1.
| Last Split Date | Jan 4, 2017 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 4 |